Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
- 19 January 2012
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 61 (8) , 1243-1253
Abstract
Background In recent years, evidence is accumulating that cancer cells develop strategies to escape immune recognition. HLA class I HC down-regulation is one of the most investigated. In addition, different HLA haplotypes are known to correlate to both risk of acquiring diseases and also prognosis in survival of disease or cancer. We have previously shown that patients with serous adenocarcinoma of the ovary in advanced surgical stage disease have a particularly poor prognosis if they carry the HLA-A02* genotype. We aimed to study the relationship between HLA-A02* genotype in these patients and the subsequent HLA class I HC protein product defects in the tumour tissue. Materials and methods One hundred and sixty-two paraffin-embedded tumour lesions obtained from Swedish women with epithelial ovarian cancer were stained with HLA class I heavy chain (HC) and β2-microglobulin (β2-m)-specific monoclonal antibodies (mAb). Healthy ovary and tonsil tissue served as a control. The HLA genotype of these patients was determined by PCR/sequence-specific primer method. The probability of survival was calculated using the Kaplan–Meier method, and the hazard ratio (HR) was estimated using proportional hazard regression. Results Immunohistochemical staining of ovarian cancer lesions with mAb showed a significantly higher frequency of HLA class I HC and β2-m down-regulation in patients with worse prognosis (WP) than in those with better prognosis. In univariate analysis, both HLA class I HC down-regulation in ovarian cancer lesions and WP were associated with poor survival. In multivariate Cox-analysis, the WP group (all with an HLA-A02* genotype) had a significant higher HR to HLA class I HC down-regulation. Conclusions HLA-A02* is a valuable prognostic biomarker in epithelial ovarian cancer. HLA class I HC loss and/or down-regulation was significantly more frequent in tumour tissues from HLA-A02* positive patients with serous adenocarcinoma surgical stage III–IV. In multivariate analysis, we show that the prognostic impact is reasonably correlated to the HLA genetic rather than to the expression of its protein products.Keywords
This publication has 49 references indexed in Scilit:
- Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary MelanomaAmerican Journal of Surgical Pathology, 2011
- The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanomaCancer Immunology, Immunotherapy, 2009
- Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian CancerClinical Cancer Research, 2008
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian CarcinomaClinical Cancer Research, 2008
- Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunology, Immunotherapy, 2007
- Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian CancerClinical Cancer Research, 2007
- Analysis of HLA class I–II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancerTissue Antigens, 2007
- Novel therapeutic agents in ovarian cancerEuropean Journal of Surgical Oncology, 2006
- Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancersExperimental & Molecular Medicine, 2002
- Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5:A two-year prospective studyCancer, 1977